SGTX — Sigilon Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Sigilon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	64.1	76.1	202	123	69.6
Net Total Accounts Receivable
Net Total Receivables	0	0.136	0.177	0.059	3.46
Prepaid Expenses
Total Other Current Assets
Total Current Assets	64.5	76.9	204	126	74.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.56	12.8	19.7	16.9	11.8
Other Long Term Assets
Total Assets	67.7	90.4	225	144	87.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.2	40.4	47	34.9	31
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	66.7	77.9	78.9	67.2	48.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.974	12.4	146	77.2	39.1
Total Liabilities & Shareholders' Equity	67.7	90.4	225	144	87.3
Total Common Shares Outstanding